USE IN PREGNANCY
When used in pregnancy during the second and third trimesters, drugs that act directly on the renin-angiotensin system can cause injury and even death to the developing fetus. When pregnancy is detected, HYZAAR should be discontinued as soon as possible. See WARNINGS, Fetal/Neonatal Morbidity and Mortality.
|
| |
HYZAAR SUMMARY
USE IN PREGNANCY
HYZAAR 50-12.5 (losartan potassium-hydrochlorothiazide) and HYZAAR 100-25 (losartan potassium-hydrochlorothiazide), combines an angiotensin II receptor (type AT1) antagonist and a diuretic, hydrochlorothiazide.
HYZAAR is indicated for the treatment of hypertension. This fixed dose combination is not indicated for initial therapy of hypertension, except when the hypertension is severe enough that the value of achieving prompt blood pressure control exceeds the risk of initiating combination therapy in these patients (see CLINICAL PHARMACOLOGY, Pharmacodynamics and Clinical Effects, and DOSAGE AND ADMINISTRATION).
|
NEWS HIGHLIGHTSMedia Articles Related to Hyzaar (Losartan / Hydrochlorothiazide)
losartan and hydrochlorothiazide, Hyzaar
Source: MedicineNet candesartan Specialty [2012.04.25]
Title: losartan and hydrochlorothiazide, Hyzaar
Category: Medications
Created: 3/12/2000 4:14:00 PM
Last Editorial Review: 4/25/2012 12:00:00 AM
Managing Hypertension - Using Single Tablet Regimens
Source: Hypertension News From Medical News Today [2012.05.04]
The Journal of Medical Economics reveals that hypertensive patients who are treated with a single tablet regimen (STR) as part of their therapy had a considerable reduction in serious cardiovascular events at a neutral cost as compared with individual component therapies...
Teens With Abnormal Levels Of Uric Acid At Increased Risk For Hypertension
Source: Gout News From Medical News Today [2012.05.03]
Teens with high levels of uric acid appear to be at increased risk for high blood pressure, according to results of research from scientists at Johns Hopkins Children's Center...
Pulmonary Arterial Hypertension - Phase III SERAPHIN Outcome Study Meets Primary Endpoint
Source: Cardiovascular / Cardiology News From Medical News Today [2012.05.02]
The initial analysis of Actelion's macitentan, a novel dual endothelin receptor antagonist that resulted from a tailored drug discovery process, has met its primary endpoint in a pivotal, long term, event-driven SERAPHIN Phase III trial...
Triple Combination Therapy Proves Effective For Treating Hypertension
Source: Hypertension News From Medical News Today [2012.05.02]
Results from two studies were presented at the 22nd European Society of Hypertension (ESH) in London highlighting the benefits of triple combination therapy for individuals suffering from hypertension. The results add to clinical understanding of olmesartan(O)/amlodipine(A)/hydrochlorothiazide(H) (O/A/H) triple combination therapy (Sevikar HCT®)...
Published Studies Related to Hyzaar (Losartan / Hydrochlorothiazide)
Safety and benefits of a tablet combining losartan and hydrochlorothiazide in Japanese diabetic patients with hypertension. [2009.12]
This study was conducted to determine the effects of a tablet combining losartan/hydrochlorothiazide (L/HCTZ) in comparison with losartan alone in Japanese diabetic patients with hypertension. Thirty consecutive Japanese diabetic patients with hypertension were randomly assigned to group A, receiving losartan alone for the first 3 months, then L/HCTZ for the next 3 months, or group B, receiving L/HCTZ for the first 3 months, then losartan alone for the next 3 months...
A randomized, comparative study evaluating the efficacy and tolerability of losartan-low dose chlorthalidone (6.25 mg) combination with losartan-hydrochlorothiazide (12.5 mg) combination in Indian patients with mild-to-moderate essential hypertension. [2009.07]
OBJECTIVE: The relationship of blood pressure (BP) to cardiovascular risk is linear, positive, and continuous. Lowering elevated BP reduces the risk of cardiovascular events. The primary objective of this randomized, multicenter, comparative, 3-month, open-label study was to evaluate the antihypertensive efficacy of losartan/chlorthalidone versus losartan/hydrochlorothiazide in mild-to-moderate essential hypertension... CONCLUSIONS: The losartan/low-dose chlorthalidone (6.25 mg) combination is as effective as the widely used losartan/hydrochlorothiazide combination in lowering BP and is well tolerated, thus providing a useful therapeutic option for treating mild-to-moderate hypertension.
Effectiveness of open-label losartan/hydrochlorothiazide combination therapy in Asian patients with hypertension not controlled with ACE inhibitor or ARB monotherapy. [2009.06]
Antihypertensive efficacy and safety of losartan/hydrochlorothiazide (HCTZ) combinations have not been adequately studied in Asians. In this open-label, 12-week study in seven Asian areas, patients on monotherapy with angiotensin receptor blockers (ARBs) or angiotensin-converting enzyme inhibitors (ACEIs) but not at blood pressure (BP) goal (sitting diastolic BP (SiDBP) <90 mm Hg in non-diabetics and <80 mm Hg in diabetics) were switched to losartan 50 mg/HCTZ 12.5 mg...
Comparison of therapies between fixed-dose telmisartan/hydrochlorothiazide and losartan/hydrochlorothiazide in patients with mild to moderate hypertension. [2009.01]
Among angiotensin receptor blockers (ARBs), telmisartan is suggested to function as a partial agonist of peroxisome proliferator-activated receptor-gamma (PPAR gamma) and to improve lipid and glucose metabolism. Clinical benefits of telmisartan over other ARBs may be apparent in combination with diuretics, which have harmful influences on lipid and glucose metabolism...
Ambulatory blood pressure comparison of the anti-hypertensive efficacy of fixed combinations of irbesartan/hydrochlorothiazide and losartan/hydrochlorothiazide in patients with mild-to-moderate hypertension. [2005.11]
This study examined whether the greater anti-hypertensive efficacy of irbesartan monotherapy over losartan monotherapy extends to the respective fixed-dose combinations with hydrochlorothiazide (HCTZ) in patients with mild-to-moderate hypertension. Patients were treated with either irbesartan 150 mg/HCTZ 12.5 mg or losartan 50 mg/HCTZ 12.5 mg over a 4-week period.
Clinical Trials Related to Hyzaar (Losartan / Hydrochlorothiazide)
HYZAAR vs. Ramipril for Diabetes [Completed]
A study to test the safety and efficacy of HYZAAR as compared to Ramipril in patients with
type 2 diabetes mellitus (high blood sugar) and hypertension (high blood pressure).
Tarka vs. Hyzaar in Patients With Metabolic Syndrome (STAR) [Active, not recruiting]
The primary objective of this study is to determine whether impaired glucose tolerance is
improved to a greater degree by Tarka than Hyzaar in subjects with metabolic syndrome
Evaluation of the Antihypertensive Effect of Hyzaar(R) and Cognitive Function of Hypertensive Patients [Completed]
Evaluate the antihypertensive and neuroprotective effects of Hyzaar(R) in elderly subjects in
comparison with Natrilix(TM).
Evaluate the Safety and Anti-Hypertensive Efficacy of Hyzaar(R) In Patients With Mild To Moderate Essential Hypertension [Completed]
Evaluate the safety and anti-hypertensive efficacy of hyzaar(R) in patients with mild to
moderate essential hypertension.
PROBE Parallel 6-wk Treatment Comparing Telmisartan/HCT (40/12.5 or 80/12.5) With Losartan/HCT (50/12.5) Using ABPM [Completed]
To demonstrate that Telmisartan combined with Hydrochlorothiazide (MICARDIS® HCT) is superior
to Losartan with Hydrochlorothiazide (Hyzaar®) in lowering blood pressure in mild-mod
hypertensives
|
PATIENT REVIEWS / RATINGS / COMMENTSBased on a total of 6 ratings/reviews, Hyzaar has an overall score of 7.83. The effectiveness score is 9.33 and the side effect score is 7. The scores are on ten point scale: 10 - best, 1 - worst. Below are selected reviews: the highest, the median and the lowest rated.
| | Hyzaar review by 58 year old female patient | | | Rating |
| Overall rating: | |  |
| Effectiveness: | | Highly Effective |
| Side effects: | | Mild Side Effects | | |
Treatment Info |
| Condition / reason: | | high blood pressure |
| Dosage & duration: | | 50/12.5 mg taken daily for the period of 2 years |
| Other conditions: | | perennial allergic rhinitis |
| Other drugs taken: | | alavert & singulair | | |
Reported Results |
| Benefits: | | lowered blood pressure |
| Side effects: | | increased thirst; increased urination; |
| Comments: | | take 1 Hyzaar every morning |
|
| | Hyzaar review by 62 year old male patient | | | Rating |
| Overall rating: | |  |
| Effectiveness: | | Considerably Effective |
| Side effects: | | Moderate Side Effects | | |
Treatment Info |
| Condition / reason: | | High Blood Pressure |
| Dosage & duration: | | standard dosage once a day (dosage frequency: once per day) for the period of 3 years |
| Other conditions: | | irregular heartbeat |
| Other drugs taken: | | just vitamins | | |
Reported Results |
| Benefits: | | reduced blood pressure and less water retention in legs and ankles |
| Side effects: | | irregular heartbeat, low pulse rate...heart flutter... |
| Comments: | | When I switched to the generic brand the side effects were moderate to severe, but after returning to the non generic Hyzaar once again, the side effects were less severe and acceptable once again. I wore a heart monitor and took active blood pressure readings in order to determine if the generic brand enhanced the side effects. While still not conclusive in my mind, I've elected to pay the extra dollars for the non generic brand. |
|
| | Hyzaar review by 32 year old female patient | | | Rating |
| Overall rating: | | |
| Effectiveness: | | Considerably Effective |
| Side effects: | | Moderate Side Effects | | |
Treatment Info |
| Condition / reason: | | High Blood Pressure |
| Dosage & duration: | | 25mg taken once daily for the period of 6 months |
| Other conditions: | | None |
| Other drugs taken: | | None | | |
Reported Results |
| Benefits: | | Lower my blood pressure out of the Prehypertension range |
| Side effects: | | Tingling in legs (low potassium) which is expected. Unfortunately, it made my heart reate higher & irregular at times (slight flutters) thorughout the day. Ultimately it was difficult to exert myself during exercise b/c I would become exhausted and ouut of breath quickly due to elevated heart rate |
| Comments: | | Simply take the dosage once a day at the same time and monitor my blood pressure |
|
|
|
Page last updated: 2012-05-04
|
